XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Mar. 30, 2024
Mar. 25, 2023
Mar. 30, 2024
Mar. 25, 2023
Operating activities:        
Net earnings $ 13,329,000 $ 6,871,000 $ 20,611,000 $ 13,504,000
Adjustments to reconcile net earnings to net cash provided by operating activities        
Depreciation of fixed assets 15,800,000 13,800,000 30,960,000 27,236,000
Amortization of intangibles and deferred costs     3,232,000 3,385,000
(Gain) loss from disposals of property & equipment     (17,000) (354,000)
Share-based compensation     3,208,000 2,552,000
Deferred income taxes     377,000 (787,000)
(Gain) loss on marketable securities 0 (59,000) 0 (22,000)
Other     160,000 (255,000)
Changes in assets and liabilities, net of effects from purchase of companies        
Decrease in accounts receivable     20,110,000 10,541,000
Decrease (Increase) in inventories     (17,027,000) 823,000
Decrease in prepaid expenses     1,046,000 4,787,000
(Decrease) in accounts payable and accrued liabilities     (962,000) (25,739,000)
Net cash provided by (used in) operating activities     61,698,000 35,671,000
Investing activities:        
Purchases of property, plant and equipment (16,696,000) (18,214,000) (36,626,000) (49,124,000)
Proceeds from redemption and sales of marketable securities     0 5,300,000
Proceeds from disposal of property and equipment     152,000 797,000
Net cash (used in) investing activities     (36,474,000) (43,027,000)
Financing activities:        
Proceeds from issuance of stock     6,516,000 4,059,000
Borrowings under credit facility     35,000,000 92,000,000
Repayment of borrowings under credit facility     (45,000,000) (55,000,000)
Payments on finance lease obligations (25,000) (32,000) (110,000) (71,000)
Payment of cash dividend     (28,444,000) (26,914,000)
Net cash provided by (used in) financing activities     (32,038,000) 14,074,000
Effect of exchange rates on cash and cash equivalents     878,000 1,384,000
Net increase (decrease) in cash and cash equivalents     (5,936,000) 8,102,000
Cash and cash equivalents at beginning of period     49,581,000 35,181,000
Cash and cash equivalents at end of period $ 43,645,000 $ 43,283,000 $ 43,645,000 $ 43,283,000